wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33728138-12BC8D6F-3B7E-4E12-B6A7-DC59E29D0ED9
Q33728138-12BC8D6F-3B7E-4E12-B6A7-DC59E29D0ED9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33728138-12BC8D6F-3B7E-4E12-B6A7-DC59E29D0ED9
Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.
P2860
Q33728138-12BC8D6F-3B7E-4E12-B6A7-DC59E29D0ED9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33728138-12BC8D6F-3B7E-4E12-B6A7-DC59E29D0ED9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1250d2756c972954db5e9e28363128be27557aaf
P2860
Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.